- Home
- CAH vs EW Comparison
CAH vs EW Comparison
Compare CAH & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAH | EW |
|---|---|---|
| Founded | 1979 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4B | 45.5B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | CAH | EW |
|---|---|---|
| Price | $198.38 | $83.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 21 |
| Target Price | ★ $200.25 | $94.89 |
| AVG Volume (30 Days) | 2.4M | ★ 3.4M |
| Earning Date | 01-29-2026 | 10-30-2025 |
| Dividend Yield | ★ 1.03% | N/A |
| EPS Growth | ★ 27.25 | N/A |
| EPS | ★ 6.63 | 2.33 |
| Revenue | ★ $234,310,000,000.00 | $5,883,800,000.00 |
| Revenue This Year | $16.60 | $14.26 |
| Revenue Next Year | $8.92 | $9.77 |
| P/E Ratio | ★ $29.91 | $36.02 |
| Revenue Growth | 4.39 | ★ 10.60 |
| 52 Week Low | $114.60 | $65.94 |
| 52 Week High | $214.93 | $87.89 |
Technical Indicators
Market Signals| Indicator | CAH | EW |
|---|---|---|
| Relative Strength Index (RSI) | 50.58 | 49.94 |
| Support Level | $197.81 | $83.08 |
| Resistance Level | $202.22 | $87.89 |
| Average True Range (ATR) | 3.60 | 1.68 |
| MACD | -2.98 | -0.49 |
| Stochastic Oscillator | 5.24 | 17.96 |
Price Performance
Historical ComparisonAbout CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.